Related Experiment Videos

[Chlamydial infection in asthma. Macrolide treatment]

Magdalena Kosińska1, Maria Kraus-Filarska

  • 1Katedra i Klinika Chorób Wewnetrznych, Geriatrii i Alergologii we Wrocławiu. wroblaha@yahoo.com

Pneumonologia I Alergologia Polska
|December 17, 2009
PubMed

Insights

Atypical infections like Chlamydophila pneumoniae worsen asthma. Macrolide antibiotics may offer additional benefits beyond antibacterial action for asthma patients.

Area of Science:

  • Microbiology and Immunology
  • Respiratory Medicine

Context:

  • Atypical microorganism infections, notably Chlamydophila pneumoniae, are increasingly recognized for their impact on asthma.
  • Chlamydial infections are linked to increased asthma exacerbation severity and chronic symptom burden.

Purpose:

  • To explore the role of atypical infections in asthma.
  • To evaluate the potential therapeutic benefits of macrolides in asthma management.

Summary:

  • Chlamydophila pneumoniae infections significantly influence asthma severity and chronicity.
  • Macrolides exhibit potent antibacterial activity against atypical microorganisms.
  • Macrolides possess anti-inflammatory and immunomodulatory properties relevant to asthma treatment.

Impact:

  • Macrolide therapy may provide additional benefits for asthma patients beyond standard treatment.
  • Further research is needed to fully elucidate the mechanisms of macrolide action in asthma.

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...